Novavax INC Form 4 insider transactions

Director James F. Young reported transactions involving Novavax Inc. stock, including the acquisition and disposal of shares and derivative securities.

Filip Dubovsky, President of R&D at Novavax, exercised stock options and sold shares on May 14, 2024.

EVP, CCO and CBO of Novavax, John Trizzino, reports the acquisition of 144,000 restricted stock units on March 1, 2024.

Elaine O'Hara, EVP and Chief Strategy Officer of Novavax, reported the acquisition of 120,000 restricted stock units (RSUs) on March 1, 2024.

James Patrick Kelly, EVP, CFO & Treasurer of Novavax, acquired 176,000 restricted stock units on March 1, 2024, according to a Form 4 filing with the SEC.

Filip Dubovsky, President of R&D at Novavax, acquired 144,000 restricted stock units on March 1, 2024, according to a Form 4 filing with the SEC.

Mark J. Casey, EVP, CLO & Corporate Secretary of Novavax, reports the acquisition of 12,000 restricted stock units on March 1, 2024.

Novavax CEO John C. Jacobs reports the acquisition of stock options and restricted stock units (RSUs) as part of an incentive plan.

James Patrick Kelly, EVP, CFO and Treasurer of Novavax, reports a transaction involving common stock and restricted stock units on March 10, 2024.

Filip Dubovsky, President of R&D at Novavax, reported the vesting and subsequent disposal of restricted stock units (RSUs) and common stock.

John Trizzino, President and COO of Novavax, reports the vesting and subsequent sale of restricted stock units.

Filip Dubovsky, President of R&D at Novavax, reported the vesting and subsequent disposal of shares related to restricted stock units.

EVP, CCO and CBO of Novavax, John Trizzino, reports the vesting and subsequent disposal of restricted stock units.

James Patrick Kelly, EVP, CFO and Treasurer of Novavax, reports transactions involving common stock and restricted stock units.

EVP and Chief Strategy Officer of Novavax, Elaine O'Hara, reports the vesting and subsequent disposal of shares to cover tax obligations.